Uric Acid-13C3

CAS : 69-93-2

Ref. TR-U829204

Informations sur le produit

• Nom: Uric Acid-13C3
• Synonymes: 7,9-Dihydro-1H-Purine-2,6,8(3H)-trione-13C3, 1H-Purine-2,6,8-triol-13C3, 2,6,8-Trihydroxypurine-13C3, 2,6,8-Trioxopurine-13C3, 2,6,8-Trioxypurine-13C3, Lithic Acid-13C3, NSC 3975-13C3, Purine-2,6,8(1H,3H,9H)-trione-13C3, 1H-Purine-2,6,8(3H)-trione, 7,9-dihydro-, 1H-Purine-2,6,8-triol, 2,3,6,7,8,9-Hexahydro-1H-purine-2,6,8-trione, 2,6,8-Trihydroxypurine, 2,6,8-Trioxopurine, 2,6,8-Trioxypurine, 6,8(3H)-trione,7,9-dihydro-1H-Purine-2, 7,9-Dihydro-1H-purine-2,6,8(3H)-trione, 8(3H)-Trione,7,9-Dihydro-1H-Purine-6, Acide urique, Acido Urico, Harnsaure, Lithic acid, Nsc 3975, Purine-2,6,8(1H,3H,9H)-trione, Purine-3,6,8(1H,3H,9H)-trione, Uric acid hyperuricemia
• CAS: 69-93-2

Description

Applications Isotope labelled Uric Acid is a heterocyclcic compound that is created when purine nucleotides are broken down of by the human body. High blood concetration of Uric Acid is known as hyperuricemia and is often associated with a wide range of disorders and medical conditions such as gout, diabetes and metabolic syndrome. Uric acid may be a marker of oxidative stress and may have a potential therapeutic role as an antioxidant.
References Heinig, M. et al.: Cle. Clin. J. Med., 73, 1059 (2006); Glantzounis, G.K. et al.: Curr. Pharmac. Des., 11, 4145 (2005); Dehghan, A. et al.: Diab. Care, 31, 361 (2008); Nakagawa, T. et al.: Am. J. Physiol. Renal Physiol., 290, F625 (2006);

• Marque: TRC

Propriétés chimiques

• Masse moléculaire: 171.09
• Formule: C₂C₃H₄N₄O₃
• Couleur/Forme: Neat
• InChI: InChI=1S/C5H4N4O3/c10-3-1-2(7-4(11)6-1)8-5(12)9-3/h(H4,6,7,8,9,10,11,12)/i1+1,2+1,3+1
• Code InChI: InChIKey=LEHOTFFKMJEONL-VMIGTVKRSA-N
• SMILES: O=c1[nH][13c](=O)[13c]2[nH]c(=O)[nH][13c]2[nH]1